Abstract
This drug-focused article looks at the pharmacodynamics and pharmacokinetics of ivabradine and outlines its use in chronic heart failure. It puts the use of ivabradine into the context of other pharmacological management and gives guidance on initiation and monitoring, as well as what clinical factors need to be taken into account to ensure safe management of patients prescribed this medication. This includes the information that needs to be shared with the patient, the criteria for eligibility, and contraindications for this treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
